Stock Events

Stock Events

Interpace Biosciences 

$6.70
3
-$0.28-4.01% Thursday 17:53

Statistics

Day High
6.87
Day Low
6.45
52W High
7.8
52W Low
0.77
Volume
3,700
Avg. Volume
5,849
Mkt Cap
185.6M
P/E Ratio
1.78
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2023
Next
0.55
0.88
1.22
1.55
Expected EPS
N/A
Actual EPS
N/A

Financials

63.46%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
38.73MRevenue
24.58MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IDXGD. It's not an investment recommendation.
Apple
2
AAPL
Microsoft
2
MSFT
Tesla
2
TSLA
Amazon
2
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health operates in the precision oncology field, offering liquid biopsy tests that compete with Interpace's diagnostic tests for cancer.
Myriad Genetics
MYGN
Mkt Cap302.25M
Myriad Genetics specializes in molecular diagnostic tests, including for cancer, directly competing with Interpace's diagnostic testing services.
Fulgent Genetics
FLGT
Mkt Cap539.57M
Fulgent Genetics provides comprehensive genetic testing solutions, competing in the genetic testing market alongside Interpace Biosciences.
Qiagen NV
QGEN
Mkt Cap8.9B
TG Therapeutics
TGTX
Mkt Cap8.26B
TG Therapeutics focuses on innovative treatments for cancer, indirectly competing with Interpace by offering alternative solutions to cancer diagnosis and treatment.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, indirectly competing with Interpace in the genetic diagnostics market.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers sequencing systems that compete in the broader market of genetic analysis, including diagnostics, where Interpace operates.

About

INTERPACE BIOSCIENCES INC
Show more...
CEO
Thomas W. Burnell
Employees
102
Country
United States
ISIN
US46062X4025

Listings

MU
DE
PF42.MU
STU
DE
PF42.STU
OTCM
US
IDXG
OTC Link
US
IDXGD

0 Comments

Share your thoughts

FAQ

What is Interpace Biosciences stock price today?▼
The current price of IDXGD is $6.70 USD — it has decreased by -4.01% in the past 24 hours. Watch Interpace Biosciences stock price performance more closely on the chart.
What is Interpace Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Interpace Biosciences stocks are traded under the ticker IDXGD.
What is Interpace Biosciences market cap?▼
Today Interpace Biosciences has the market capitalization of 185.6M
When is the next Interpace Biosciences earnings date?▼
Interpace Biosciences is going to release the next earnings report on November 11, 2026.
What is Interpace Biosciences revenue for the last year?▼
Interpace Biosciences revenue for the last year amounts to 38.73M USD.
What is Interpace Biosciences net income for the last year?▼
IDXGD net income for the last year is 24.58M USD.
How many employees does Interpace Biosciences have?▼
As of September 04, 2026, the company has 102 employees.
In which sector is Interpace Biosciences located?▼
Interpace Biosciences operates in the Health & Wellness sector.
When did Interpace Biosciences complete a stock split?▼
Interpace Biosciences has not had any recent stock splits.
Where is Interpace Biosciences headquartered?▼
Interpace Biosciences is headquartered in Parsippany, United States.